The Losartan Renal Protection Study--Rationale, Study Design and Baseline Characteristics of RENAAL (Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartan).

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System - United Kingdom
doi 10.3317/jraas.2000.062
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial

Hypertension
Internal Medicine
2011English

Effect of the Angiotensin II Receptor Antagonist Losartan on Uric Acid and Oxypurine Metabolism in Healthy Subjects.

Internal Medicine
Internal MedicineMedicine
2002English

Long-Term Effects of Angiotensin II Receptor Antagonist Losartan on Uric Acid Metabolism in Hyperuricemic Patients

Gout and Nucleic Acid Metabolism
2002English

Clinical Usefulness of Losartan, an Angiotensin II Receptor Antagonist With a Uricosuric Effect, and the Influence of Aspirin on the Effect in Hypertensive Patients With Hyperuricemia

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2003English

Rationale, Design, and Baseline Characteristics of the Cardiovascular Prognostic COUPLING Study in Japan (The COUPLING Registry)

Journal of Clinical Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2020English

Study the Nephro-Protective Effects of Losartan on Rats

International Journal of Clinical Pharmacology & Pharmacotherapy
2016English

Subtypes of Losartan-Sensitive Angiotensin Receptor in the Rabbit Pulmonary Artery

British Journal of Pharmacology
Pharmacology
1996English

The Rationale, Design, and Baseline Characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y)

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2013English

Seasonal Dosage-Dependent Hypersensitivity to the Angiotensin II Receptor Blocker, Losartan. A Case Report and Review

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy